Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ELAD in Severe Acute Alcoholic Hepatitis (sAAH) with Lille Score Failure
NCT01829347Phase 3Terminated
- Sponsor
- Vital Therapies, Inc.
- Start
- Apr 2014
- Primary completion
- Oct 2015
- Modality
- Cell Therapies, Device-based Delivery
- Countries
- 4
01
Overview
A Phase 3 trial of ELAD in acute alcoholic hepatitis (AH), sponsored by Vital Therapies, Inc.. Started Apr 2014; status: terminated.
02
Drugs
ELAD
03
Conditions
acute alcoholic hepatitis (AH)
Beyond the preview
Go deeper on NCT01829347.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01829347.